Bilateral Panuveitis at Etanercept Initiation for Juvenile Idiopathic Arthritis

Ben Abdelghani, Kaouther and Slouma, Marwa and Hajri, Rym and Souabni, Leila and Zakraoui, Leith (2014) Bilateral Panuveitis at Etanercept Initiation for Juvenile Idiopathic Arthritis. European Journal of Case Reports in Internal Medicine, 1 (1). pp. 1-5. ISSN 2284-2594

[img]
Preview
Text
36-439-7-PB.pdf - Published Version

Download (271kB) | Preview
Official URL: http://ejcrim.com/index.php/EJCRIM/article/view/36

Abstract

Introduction: Uveitis is a well-known extra-rheumatological manifestation of juvenile idiopathic arthritis (JIA). Tumor necrosis factor has been used to treat uveitis associated with inflammatory diseases. A new onset uveitis under anti-TNF therapy is uncommon. Case presentation: A 12-years-old male, affected since the age of six years, by a severe form of polyarticular JIA. When etanercept was started, he presented panuveitis bilaterally, so we switched to infliximab with good response. Conclusions: The TNF soluble receptor could be considered as a possible promoter in inducing endogenous new onset uveitis in JIA.

Item Type: Article
Uncontrolled Keywords: Anti-TNF therapy; etanercept; juvenile idiopathic arthritis; paradoxical effect; uveitis
Subjects: 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale)
Depositing User: Chiara D'Arpa
Date Deposited: 07 Sep 2016 15:50
Last Modified: 07 Sep 2016 15:50
URI: http://eprints.bice.rm.cnr.it/id/eprint/14980

Actions (login required)

View Item View Item